Full text is available at the source.
Abstract
The glucagon-like peptide-1 receptor (GLP-1R) is a significant target in treating obesity and metabolic diseases.
- GLP-1R plays a crucial role in regulating appetite, gastric emptying, insulin secretion, and energy balance.
- Pharmacological GLP-1R agonists are associated with significant weight loss and improvements in blood sugar levels.
- There is increasing interest in natural dietary components that may enhance the body's own GLP-1 signaling.
Simplified